Announcement of sites in Germany
Announcement of more sites in the UK
Announcing of more sites in the US
Announcement of first patient results of the blinded phase 1 DCVax direct trials on inoperable solid tumors
1st interim analysis on DCvax-L phase 3 on GBM before end 2013 with possible BLA status given by the FDA data monitoring board
Announcement for partnership to start phase 3 DCVax prostate
Each announcement is a ticking time bomb!
30 million shares outstanding and no LT debt
Sorry Anni... looks like investors are running for the door.... There is tiredness I sense coming from this company... you can only test the patience of investors for so long. It is called hubris. And NWBO management has lots of it.